Dexcom | DXCM - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Abbott USD 6.8B 1.72B 2026-03
Align Technology USD 1.1B 42.76M 2026-06
AtriCure USD 167.79M 21.62M 2026-06
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Boston Scientific USD 539M 914M 2026-06
Cooper Companies USD 124.9M 14.3M 2025-12
Dexcom USD 1.1B 13.2M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Globus Medical USD 507.74M 53.2M 2026-06
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 534.9M 54.5M 2026-06
Integra LifeSciences USD 214.42M 22.39M 2026-06
J&J USD 20.42B 1.27B 2026-06
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 448.7M 39.38M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Solventum Corp USD 403M 158M 2026-06
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 62.82M 116.51M 2026-06
Teleflex USD 300.16M 9.25M 2026-06
West Pharmaceutical Services USD 435.8M 85.6M 2026-06
Zimmer Biomet Holdings USD 410M 14.2M 2026-06